Focus on Asthma Care

Back to articles

New data shed light on safety of long-acting beta-2 agonist combos in asthma

KEY POINT

The combination of an inhaled corticosteroid (ICS) and a long-acting beta-2 agonist (LABA) protects against severe asthma exacerbations as well or better than an ICS alone in a diverse population of patients with asthma, according to a recent observational trial.